Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Evoke Pharma Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 3.16M | 3.15M | −11.5K (−0.4%) |
| Value | $1.93M | $1.67M | −$262.3K (−13.6%) |
New holders (4)
Institutions that held Evoke Pharma Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 11,911 | $6.30K | 0.00% |
| State Street Corp | 10,660 | $5.64K | 0.00% |
| FMR LLC | 71 | $38 | 0.00% |
| Bank of America Corp | 69 | $37 | 0.00% |
Sold out (3)
Institutions that held Evoke Pharma Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Goldman Sachs Group Inc | 13,471 | $8.22K |
| Millennium Management LLC | 10,869 | $6.63K |
| Wells Fargo & Company | 66 | $40 |